An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.
Hailey Coverson, Data Scientist at Bayezian, discusses the complexities of genomic data, accounting for biases and inaccuracies and AI’s potential in supporting clinical decisions in breast cancer care.
Researchers at the University of Notre Dame have a development in cancer therapy: a miniature, wireless LED device that can be implanted directly into deep-seated tumours.
Dr Mark Verrill, Consultant Medical Oncologist at the Northern Centre for Cancer Care, discusses the importance of personalised breast cancer treatment.
Long waits for cancer care have become normal across the UK, with nearly half of all specialist cancer centres experiencing delays most weeks, according to the Royal College of Radiologists (RCR).
In a study, researchers from the University of Basel and the University Hospital Basel have uncovered a promising new approach to combat the Epstein-Barr virus (EBV), a common virus that affects 90% of the adult population.
In a significant advancement for breast cancer treatment, a new blood test has shown the ability to predict the recurrence of breast cancer up to three years before tumours become detectable through conventional scans.
The University of Michigan Health Rogel Cancer Center has revealed that changing the dosing schedule for common cancer therapy could greatly reduce greenhouse gas emissions without compromising the patient's outcomes.
63.8% of the UK population are currently overweight or obese. Obesity is a major cause of ill health. Being moderately obese takes around 3 years off your life, whereas severe obesity shortens it by at least 10 years.
In a recent study, researchers at the University of California San Diego have developed an experimental treatment made from a plant virus that shows effectiveness in protecting against a broad range of metastatic cancers in mice.
Zisis Kozlakidis from the World Health Organization’s International Agency for Cancer and Jiaao Yu from the Shanghai Jiao Tong University discuss the burden of lung cancer in Southeast Asia and China and the priorities for therapies and interventions.
Lorna Rothery spoke to the Cancer Drug Development Forum’s Managing Director, Professor Jaap Verweij and Chairperson of the CDDF Board of Directors, Professor Ruth Plummer, about opportunities and challenges in oncology research and treatment.
A scarcity of suitable therapies and geographic disparities in access to care are impacting survival rates for children with cancer; Lorna Rothery spoke to the European branch of Childhood Cancer International, a pan-European organisation committed to improving outcomes for children and adolescents affected by cancer.
